Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05402267
Other study ID # OME-2022
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 1, 2022
Est. completion date May 1, 2024

Study information

Verified date May 2022
Source Eye & ENT Hospital of Fudan University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The particularity of adenoids, as a reservoir of bacterial pathogens and immune molecules, is known to be significantly involved in children with otitis media with effusion (OME). As an important carrier of intercellular substance transfer and signal transduction, exosomes with different biological functions can be secreted by different types of cells. There remains significant uncertainty regarding the clinical transmitter of exosomes to OME, especially in its pathophysiologic development. In this study, the investigators try to elucidate the biological functions of exosomes in children with adenoid hypertrophy accompanied by OME. Patients with adenoid hypertrophy or otitis media will be separated into three groups: those with adenoid hypertrophy, with otitis media and with adenoid hypertrophy and otitis media both, as well as a healthy control group. Participants in the four groups will have their middle ear effusion, nasopharyngeal secretion, and peripheral blood samples taken, from which exosomes will be separated for further analysis. Adenoidectomy will be conducted in adenoid hypertrophy accompanied by OME and adenoid hypertrophy alone and their adenoid tissue will be collected. Blood will be collected again 3 months after surgery and middle ear and nasopharyngeal examinations will be performed. Exosomes will be isolated for follow-up studies as before surgery. Investigators will also use proteome research, exosome biomarkers, and high-throughput sequencing to examine the pathophysiology of OME, particularly inflammation-related etiology, in order to provide novel ideas for OME diagnosis and treatment.


Description:

This study will explore the pathogenesis of OME by detecting the exosome in middle ear fluid, nasopharyngeal secretions and peripheral blood in order to identify areas of opportunity for future research and to provide a theoretical basis for drug development for the treatment of secretory otitis media. 240 subjects will be recruited from Eye and ENT hospital of Fudan University or the community. They will be divided into four groups: adenoid hypertrophy accompanied by OME (group OA, n=60), adenoid hypertrophy alone (group CA, n=60), OME alone (group CO, n=60) and healthy control group (children without OME or adenoid hypertrophy, n=60). All participants will undergo the examinations of middle ear and nasopharynx in addition to blood collection when they get into the groups. The exosomes will be isolated form middle ear effusions, nasopharyngeal secretions/adenoid tissue, and peripheral blood collected from all participants. The OA and CA groups will undergo adenoidectomy and their adenoid tissue will be collected. Blood will be collected again 3 months after surgery and middle ear and nasopharyngeal examinations will be performed. Exosomes will be isolated for follow-up studies as before surgery. The primary outcome measures will be (1) ANOVA of the alterations and related gene expression of exosome contents in nasopharyngeal secretions in the four groups; (2) microbial alterations and the exosomes from biofilm on the surface of the adenoids in OA and CA groups preoperative and postoperative; and (3) the differences of exosomes from peripheral blood samples in OA and CA groups preoperative and postoperative.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 240
Est. completion date May 1, 2024
Est. primary completion date December 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Years to 10 Years
Eligibility Inclusion Criteria: OME-Adenoid (OA) group: 1. Children aged between 4 and 10 years old. 2. Diagnosis of chronic otitis media with effusion, and the course of disease is at least 3 months. 3. There are varying degrees of hearing loss. PTA (The mean hearing threshold of 500Hz, 1000Hz and 2000Hz) = 30dB. 4. Nasopharyngeal lateral X-ray showing A/N > 0.6 of adenoids. Control-Adenoid (CA) group: 1. Children aged between 4 and 10 years old. 2. Nasopharyngeal lateral X-ray showing A/N > 0.6 of adenoids. Control-OME (CO) group: 1. Children aged between 4 and 10 years old. 2. Diagnosis of chronic otitis media with effusion, and the course of disease is at least 3 months. 3. There are varying degrees of hearing loss. PTA (The mean hearing threshold of 500Hz, 1000Hz and 2000Hz) = 30dB. Exclusion Criteria: 1. Patients who have had one or more episodes of otitis media in the previous one year. 2. Any immunologic diseases. 3. Any intrinsic diseases of hearing system, anatomic or physiologic defect of the ear. 4. Pharmacologic abnormality.

Study Design


Intervention

Procedure:
Adenoidectomy
Adenoidectomy will be conducted in OA and CA groups

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Eye & ENT Hospital of Fudan University

Outcome

Type Measure Description Time frame Safety issue
Primary differential gene expression ANOVA of the alterations and related gene expression of exosome contents in nasopharyngeal secretions in the four groups 3 months
Primary detection of adenoids microbial alterations and the exosomes from biofilm on the surface of the adenoids in OA and CA groups preoperative and postoperative 3 months
Primary detection of exosomes the differences of exosomes from peripheral blood samples in OA and CA groups preoperative and postoperative 3 months
See also
  Status Clinical Trial Phase
Completed NCT03590912 - Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion Phase 4
Completed NCT03611842 - Study of the Expression of MMPs in OME in Children With Atrophy of the Eardrum
Not yet recruiting NCT01421199 - Device Study to Evaluate the Detection and Characterization of Middle Ear Fluid in Children N/A
Completed NCT01202578 - Evaluation of the Tympanostomy Tube Delivery System Phase 2/Phase 3
Completed NCT00520039 - Osteopathic Otitis Media Research Study N/A
Completed NCT00629694 - Adenoidectomy, Myringotomy and Tubes' Insertion vs Adenoidectomy and Myringotomy Alone in Children With Otitis Media With Effusion and Adenoid Hypertrophy Phase 2
Completed NCT00195611 - Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media Phase 4
Not yet recruiting NCT04584073 - Secretory Otitis Media in Adenoids Hypertrophy Patients N/A
Withdrawn NCT00736112 - Food Allergy - Tubes - Adenoids (FATA) Trial N/A
Completed NCT00546117 - A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion N/A
Withdrawn NCT02950311 - Xylitol for Otitis Media Phase 2/Phase 3
Recruiting NCT05324696 - Autoinflation: Alternative in the Treatment of Otitis Media With Effusion N/A
Recruiting NCT05353569 - Coherent Optical Detection of Middle Ear Disease N/A
Completed NCT02282540 - Novel Imaging of the Eustachian Tube; Patient Study N/A
Not yet recruiting NCT03491098 - The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study Early Phase 1
Completed NCT01082029 - Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children Phase 4
Completed NCT00939796 - Clinical Study of the Tympanostomy Tube Delivery System N/A
Recruiting NCT06316635 - Microplastics in Otitis Media With Effusion Material
Recruiting NCT02215681 - Acupuncture Effect on Inflammatory Markers in Pediatric Otitis Media With Effusion: A Pilot Study N/A
Completed NCT02183961 - Three Methods Used in the Diagnosis of EER in Children With OME N/A